Regulated information

Monthly information regarding the total number of voting rights and shares - march 2022

Monthly information regarding the total number of voting rights and shares making of the share capital

as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

2021 Annual results

ALL FINANCIAL INDICATORS UP.
Annual sales: €521m (up 21.9% as reported).
Essentials sales: €296m (up 34.0% as reported).
EBIT before depreciation of acquired assets: €101m (up 54.5%).
Net income - Group share: €63m (up 226.9%).

Annual results 2021 (slideshow)

This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022.

[AUDIO] Présentation des résultats 2021

Présentation analystes & investisseurs - 24 mars 2022

Monthly information regarding the total number of voting rights and shares making of the share capital- february 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Buyback programs - february 2022

Buyback programs - February 2022

Buyback programs - January 2022

Double-digit growth in 2021

Total Group Sales: €521 million (up 21.9% as reported)
Annual Sale of Essential products: €296 million (up 34.0% as reported)

Clone of Monthly information regarding the total number of voting rights and shares making of the share capital

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »